Dementia isn’t a single disease. It’s a term for significant cognitive decline caused by damage to brain cells, and that damage can come from several different sources. The most common cause is Alzheimer’s disease, which accounts for 60 to 80 percent of cases, but problems with blood flow, abnormal protein buildup, and even treatable conditions like hearing loss and high blood pressure all play a role. Roughly 45% of dementia cases worldwide are tied to modifiable risk factors, meaning a substantial portion could theoretically be prevented or delayed.
Alzheimer’s Disease: Toxic Proteins That Destroy Synapses
In Alzheimer’s, two abnormal proteins gradually destroy the brain. The first, called beta-amyloid, clumps together into sticky plaques between neurons. The second, called tau, twists into tangles inside neurons themselves. For years, researchers assumed the plaques and tangles physically crushed brain cells, and they do cause structural damage in later stages. But the earlier, more insidious problem is that soluble forms of these proteins, the smaller fragments floating freely before they clump, interfere with synapses. Synapses are the tiny gaps where brain cells pass signals to each other. When those connections stop working, memory and thinking decline well before large-scale brain shrinkage becomes visible on a scan.
The brain’s immune cells, called microglia, initially try to clean up the amyloid. But chronic exposure overwhelms them. Once overactivated, microglia start producing inflammatory molecules and reactive oxygen species that damage neurons, compromise the blood-brain barrier, and actually impair the brain’s ability to clear amyloid further. This creates a self-reinforcing cycle: more amyloid triggers more inflammation, which causes more neural tissue loss, which shows up as worsening memory and executive function.
Vascular Dementia: When Blood Flow Falls Short
The brain consumes roughly 20% of the body’s oxygen despite being only about 2% of its weight. When blood supply is compromised, neurons die. Vascular dementia is the second most common type, and more than half of vascular dementia cases stem from disease in the brain’s small blood vessels rather than a single large stroke.
Small vessel disease works in two ways. It can cause tiny infarcts (areas of dead tissue less than 5 millimeters across) scattered throughout deep brain structures like the white matter, thalamus, and basal ganglia. These microinfarcts involve neuron death, axon damage, and scarring, but they’re so small they’re often invisible on standard brain imaging. The second mechanism is chronic: damaged small arteries lose their ability to expand and contract in response to blood pressure changes, leading to fluctuations in blood flow that starve tissue of oxygen over months and years.
The cognitive profile of vascular dementia looks different from Alzheimer’s. Rather than memory loss appearing first, people typically notice problems with attention, planning, decision-making, and processing speed. Motor performance also slows. Because the risk factors for small vessel disease are the same ones that damage blood vessels everywhere in the body (high blood pressure, diabetes, smoking, high cholesterol), vascular dementia overlaps heavily with cardiovascular disease.
Lewy Body Dementia: A Different Protein, Different Symptoms
Lewy body dementia is caused by clumps of a protein called alpha-synuclein that form inside neurons. In early stages, alpha-synuclein molecules cluster into small groups called oligomers. Over time, these oligomers grow into larger fibrous structures, the Lewy bodies visible under a microscope. The damage is twofold: the protein aggregates physically disrupt cell function, and the loss of normal alpha-synuclein at synapses impairs neurotransmitter release, vesicle transport, and dopamine production.
Because dopamine-producing areas are heavily affected, Lewy body dementia shares movement symptoms with Parkinson’s disease, including stiffness, tremor, and shuffling gait. But it also produces distinctive cognitive symptoms: vivid visual hallucinations, dramatic fluctuations in alertness and attention throughout the day, and sleep disturbances where people physically act out their dreams.
Frontotemporal Dementia: Targeting Personality and Language
Frontotemporal dementia strikes the frontal and temporal lobes, the brain regions responsible for personality, behavior, and language. It tends to appear earlier than other dementias, often between ages 45 and 65. The underlying pathology involves either abnormal tau (the same protein implicated in Alzheimer’s, but behaving differently) or a protein called TDP-43 that accumulates in toxic clumps inside neurons.
Several genetic mutations can trigger frontotemporal dementia, most notably mutations in the progranulin gene. Unlike Alzheimer’s, where memory loss is the hallmark, frontotemporal dementia often first shows up as dramatic personality changes: loss of empathy, impulsive behavior, social inappropriateness, or apathy. In language-dominant variants, people progressively lose the ability to find words or understand speech.
Genetics and APOE4
The single strongest genetic risk factor for common, late-onset Alzheimer’s is a gene variant called APOE4. Everyone inherits two copies of the APOE gene (one from each parent), and each copy can be the e2, e3, or e4 version. Carrying one copy of APOE4 increases Alzheimer’s risk moderately. Carrying two copies is far more serious: people with two APOE4 copies have an estimated 60% chance of developing Alzheimer’s dementia by age 85, according to NIH research.
APOE4 is not destiny, though. Many carriers never develop dementia, and many people who develop Alzheimer’s don’t carry the variant at all. Rare genetic mutations in other genes cause early-onset familial Alzheimer’s, which can strike in a person’s 30s or 40s, but these account for a very small percentage of all cases.
14 Risk Factors You Can Actually Change
The 2024 Lancet Commission on dementia prevention identified 14 modifiable risk factors that collectively account for about 45% of dementia cases globally. These span the entire lifespan:
- Early life: limited education
- Midlife: hearing loss, traumatic brain injury, high blood pressure, excessive alcohol use, and obesity
- Later life: smoking, depression, social isolation, physical inactivity, diabetes, air pollution exposure, vision loss, and high LDL cholesterol
Hearing loss stands out as one of the most significant individual factors, estimated to account for roughly 9% of dementia cases on its own. The link isn’t just coincidence. Several plausible biological mechanisms explain it. When hearing deteriorates, the brain receives less stimulation from speech and environmental sound, effectively creating an impoverished cognitive environment that weakens neural networks over time. Struggling to hear also forces the brain to divert attention and working memory resources toward the simple act of listening, leaving fewer resources available for other thinking tasks. There’s also evidence that the altered neural activity caused by hearing loss may interact directly with Alzheimer’s pathology in the brain’s memory centers.
The addition of vision loss and high cholesterol to the 2024 list reflects growing evidence that sensory health and cardiovascular health are more tightly connected to brain health than previously appreciated. Addressing all 14 factors won’t eliminate dementia, but the potential to prevent or delay nearly half of all cases through lifestyle and medical management is striking.
Air Pollution and the Brain
Fine particulate matter (PM2.5), the tiny particles produced by vehicle exhaust, industrial emissions, and wildfires, is now recognized as a dementia risk factor. Meta-analyses estimate a 3% increase in dementia risk for every 1 microgram per cubic meter increase in long-term PM2.5 exposure. That may sound small, but PM2.5 levels vary enormously by location. People living near heavy traffic or in regions with poor air quality accumulate years of elevated exposure. The risk appears even higher for vascular dementia specifically, with one analysis of eight studies finding a 7% increase per microgram per cubic meter.
The mechanism likely involves tiny particles crossing into the bloodstream and triggering systemic inflammation, which in turn damages blood vessels in the brain and promotes the neuroinflammatory cascade that accelerates neurodegeneration.
Viral Infections and Amyloid
An emerging line of evidence connects herpes simplex virus type 1 (HSV-1), the common cold sore virus, to Alzheimer’s pathology. In mouse models, HSV-1 infection triggers amyloid-beta deposition, and repeated viral reactivations increase Alzheimer’s-related brain changes in a dose-dependent fashion. HSV-1 DNA has been found within amyloid plaques in human brains.
One of the more surprising findings is that amyloid-beta may actually function as an antimicrobial defense. The brain appears to produce it in response to HSV-1 infection, where it helps block the virus from fusing with cell membranes. This raises the possibility that amyloid buildup in Alzheimer’s is, at least partly, the brain’s immune response to infection gone haywire. The varicella zoster virus (which causes chickenpox and shingles) has also been shown to trigger amyloid production in human brain cells in lab settings. This area of research is still being investigated, but it adds a new dimension to understanding why amyloid accumulates in the first place.